Medicine: Science and humanism. Questions and thoughts about medical practice;Medicina: Ciencia y humanismo, cuestionamientos y reflexiones de la prática médica

Revista de Investigacion Clinica

Volumn 54, Issue 4, 2002, Pages 366-375

  Garber, Israel Lerman ^a  

^a Inst Nac'l de Ciencias Medicas   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DOCTOR PATIENT RELATION; DRUG INDUSTRY; EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HUMAN; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL PRACTICE; MEDICAL TECHNOLOGY; MEDICINE; PATIENT CARE; SCIENCE;

BIOMEDICAL TECHNOLOGY; CHRONIC DISEASE; CLINICAL MEDICINE; COMMUNICATIONS MEDIA; DRUG INDUSTRY; ETHICS, MEDICAL; EVIDENCE-BASED MEDICINE; HUMANISM; HUMANS; NEURODEGENERATIVE DISEASES; PHYSICIAN-PATIENT RELATIONS; RESEARCH; SCIENCE; SOCIOECONOMIC FACTORS;

EID: 0036661860     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Jinich H. Triunfos y fracasos de la Medicina en los Estados Unidos de América. Gac Méd Méx 1990; 126; 72-6.
2. Alvarez A. Una aproximación psicoanalítica a la ética de la relación médico-paciente. Rev Invest Clín 1997; 49: 491-6.
3. Frenk J. La transición altera el significado de la enfermedad. Ciencia Médica 1994; 1(2): 18-23.
4. Von Korff M, Gruman J, Schaefer J, Curry SJ, Wagner EH. Collaborative management of chronic illness. Ann Intern Med 1997; 127: 1097-102.
5. Hofman C, Rice D, Sung HY. Persons with chronic conditions, their prevalence and costs. JAMA 1996; 276: 1473-9.
6. Dirección General de Epidemiología. Instituto Nacional de la Nutrición Salvador Zubirán. Encuesta Nacional de Enfermedades Crónicas. Informe preliminar 1993. Subsecretaría de Coordinación y Desarrollo. Secretaría de Salud. México.
7. Stratton JM, Adler AL, Neil HA, Matthews DR, Manley SE, Cull SA, Hadden D, Turner RC, Colman RR. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35); prospective observational study. BMJ 2000; 321: 412-9.
8. Clark ChM, Fradkin JE, Hiss R, Lorenz RA. The National Diabetes Education Program, changing the way diabetes is treated. Comprehensive diabetes care. Diabetes Care 2001; 24: 617-8.
9. Ary DW, Toobert D, Wilson W, Glasgow RE. Patient perspective on factors contributing to non-adherence to diabetes regimen. Diabetes Care 1986; 9: 168-72.
10. Glasgow RE, Anderson RM. In diabetes care, moving from compliance to adherence is not enough. Something entirely different is needed. Diabetes Care 1999: 22: 2090-91.
11. Wing RR, Goldstein MG, Acton KJ, Birch LL, Jakicik JM, Sallis JE, Smith West D, Jeffery RW, Surwit RS. Behavioral science in diabetes. Diabetes Care 2001; 24: 117-23.
12. Haynes RB. A critical review of the determinants of patient compliance with therapeutic regimens. Compliance and therapeutic regimens. Sacket DL, Haynes RB (eds) Baltimore, Johns Hopkins University Press 1976; P 26-39.
13. López JF, Luna JMA. Cuándo y en quién hacer diagnóstico temprano de enfermedad. Rev Invest Clin 1997; 49: 67-74.
14. Meltzer MI: Introduction to health economics for physicians. Lancet 2001; 358: 993-8.
15. Gray, Raikou M, McGuirre A, Fenn P, Stevens R, Cull C. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: Economic analysis alongside randomized controlled trial (UKPDS 41). BMJ 2000; 320: 1373-8.
16. Feinstein AR. Clinical judgment revisited. The distraction of quantitative models. Ann Intern Med 1994; 120: 799-805.
17. Jinich H. Ciencia, tecnología y humanismo en Medicina. Gac Méd Méx 1990; 126: 481-6.
18. Viniegra L. El fetichismo de la tecnología. Rev Invest Clín 2000; 52: 569-80.
19. Narayan KM, Gregg EW, Engelgau MM, Moore B, Thompson TJ, Williamson DE, Vinicor F. Translation Research for Chronic disease. The case of diabetes. Diabetes Care 2000; 23: 794-8.
20. Kraus A. Carpe diem, una paciente crónica. Nexos, octubre 2001: 91-4.
21. Latapí P. Medicina, crisis profesional o crisis humana. Gac Méd Méx 1979; 115: 151-6.
22. The Editors. Looking back in the millennium in medicine. N Engl J Med 2000; 342(1): 42-9.
23. Feinstein AR. Twentieth century paradigms that threaten both scientific and human medicine in the twenty first century. J Clin Epidemiol 1996; 49: 615-7.
24. Charlton BG. The scope and nature of epidemiology. J Clin Epidemiol 1996; 49: 623-6.
25. Benítez BL. Evidence based medicine. A new paradigm? Arch Med Res 1999; 30; 77-9.
26. Bradford HA. Principles of medical statistics. 9th Ed. Lancet. London 1971.
27. Skrabanek P. The epidemiology of errors. Lancet 1993; 342: 1502.
28. Skrabanek P. The death of human medicine (and the rise of coercive healthism). Sufolk, England. Social affairs unit. St Edmundsbury Press; 1994.
29. Lopez JF, Lamas GA. Evidence based medicine. Arch Med Res 1999; 30: 80-1.
30. Hostetter TH. Prevention of end stage renal disease to type 2 diabetes. N Engl J Med 2001; 345: 910-1.
31. Ravnsov U. Cholesterol lowering trials in coronary heart disease; frequency of citation and outcome. Br Med J 1992; 305: 15-9.
32. McCormick James. Medical hubris and the public health. The ethical dimension. J Clin Epidemiol 1996; 49: 619-21.
33. Jeffery RW. Population perspectives on the prevention and treatment of obesity in minority populations. Am J Clin Nutr 1999; 53: 1621S-24S.